ANTIBODIES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Antibodies Market, By Drug Type (Monoclonal antibodies, Polyclonal antibodies, Antibody-drug complexes (ADCs), by Disease Indication (CNS Disorders, Cardiovascular, Cancer, Autoimmune Disorders, COVID-19, Others) By End User (Hospitals, Long-term Care Facilities, Research institutes), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In: 28 Apr, 2026
Code: CMI2629
Page number: 170
Formats: Excel and PDF
Industry: Biotechnology
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Type
  - Market Snapshot, By Disease Indication
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
  - Impact Analysis
  - Key Highlights
  - Product Launch
  - Technological Advancements
  - PEST Analysis
  - Regulatory Scenario
  - Mergers and Acquisitions
Global Antibodies Market, By Drug Type, 2021 – 2033, (US$ Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Monoclonal Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Polyclonal Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Antibody-drug complexes (ADCs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
Global Antibodies Market, By Disease Indication, 2021 – 2033, (US$ Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- CNS Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Cardiovascular Diseases
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Autoimmune Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$
Global Antibodies Market, By End User, 2021 – 2033, (US$ Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segments Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Long-term Care Facilities
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Research institutes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
Global Antibodies Market, By Region, 2021 – 2033, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Novartis International AG
  *
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Johnson & Johnson Services, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Biogen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bristol-Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi S.A.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eli Lilly and Co.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Iovance Biotherapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ultragenyx Pharmaceutical Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Kyowa Kirin Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 36 market data tables and 27 figures on “Global Antibodies Market” - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now